Renovascular hypertension

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 3, 2005, Pages 413-422

  Dieter, Robert S ^a   Schmidt, Wade S ^a   Pacanowski Jr , John P ^b   Jaff, Michael R ^c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Cardiovascular Medicine ^*  (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angioplasty stent; Atherosclerosis; Fibromuscular dysplasia; Ischemic nephropathy; Renal artery stenosis; Renal preservation; Renin angiotensin aldosterone system

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSERVATIVE TREATMENT; CORONARY ARTERY DISEASE; DEVICE; DRUG ELUTING STENT; ECHOGRAPHY; FIBROMUSCULAR DYSPLASIA; HUMAN; KIDNEY ARTERIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; KIDNEY PRESERVATION; LIFESTYLE; LUNG EDEMA; META ANALYSIS; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREMENOPAUSE; RENAL ARTERY; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; STENT; TREATMENT INDICATION; TREATMENT OUTCOME;

HUMANS; HYPERTENSION, RENOVASCULAR; RISK FACTORS;

EID: 18844427875     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.3.3.413     Document Type: Review

References (66)

1. Chobanian AV, Bakris GL, Black HR et al. for the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 Report. J. Am. Med. Assoc. 289, 2560-2572 (2003).
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913 (2002).
3. Vasan RS, Beiser A, Seshadri S et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. J. Am. Med. Assoc. 287, 1003-1010 (2002).
4. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25, 305-313 (1995).
5. Vasan RS, Evans JC, Larson MG et al. Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N. Engl. J. Med. 351, 33-41 (2004).
6. Nabel EG. Cardiovascular disease. N. Engl. J. Med. 349, 60-72 (2003).
7. Rudnichi A, Salar ME, Lajemi M, Benetos A. Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension. Am. J. Hypertens. 17, 321-327 (2004).
8. Buckalew VM Jr, Berg RL, Wang SR et al. Prevalence of hypertension in 1795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am. J. Kidney Dis. 28, 811-821 (1996).
9. Lanzer P, Topol EJ. Pan Vascular Medicine. Springer-Verlag, NY, USA (2002).
10. Zoccali C, Mallamaci F, Finocchiaro P. Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J. Am. Soc. Nephrol. 13(Suppl. 3), S179-S183 (2002).
11. Coen G, Calabria S, Lai S et al. Atherosclerotic ischemic renal disease. Diagnosis and prevalence in an hypertensive and/or uremic elderly population. BMC Nephrol. 4, 2 (2003).
12. van Ampting JM, Penne EL, Beek FJ et al. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol. Dial. Transplant. 18, 1147-1151 (2003).
13. Aqel RA, Zoghbi GJ, Baldwin SA et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J. Hypertens. 21, 1157-1162 (2003).
14. Rihal CS, Textor SC, Breen JF et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin. Proc. 77, 309-316 (2002).
15. Buller C, Nogareda J, Ramanathan K et al. The profile of cardiac patients with renal artery stenosis. J. Am. Coll. Cardiol. 43, 1606-1613 (2004).
16. Brewster UC, Setaro JF, Perazella MA et al. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am. J. Med. Sci. 326(1), 15-24 (2003).
17. Kimihiko K, Tatsuaki M, Kunihiko I et al. Elevated levels of proinflammatory cytokines in coronary artery thrombi. Int. J. Card. 70, 267-273 (1999).
18. Rauramaa R, Vaisanen S, Luong L et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20, 2657-2662 (2000).
19. Reilly J, Miralles M, Wester W et al. Differential expression of prostaglandin E2 and interleukin-6 in occlusive aneurismal aortic disease. Dis. Surg. 126, 624-628 (1999).
20. Schieffer B, Schieffer E, Kleiner D et al. Expression of angiotensin II and interleukin-6 in human coronary atherosclerotic plaques. Circulation 101, 1372-1378 (2001).
21. Libby P. Molecular basis of acute coronary syndromes. Circulation 91, 2844-2850 (1995).
22. Ridker P, Rifai N, Stampfer M et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101, 1767-1772 (2000).
23. Woods A, Brull D, Humphries S et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur. Heart J. 21, 1574-1583 (2000).
24. Biasucci L, Vitelli A, Liuzzo G et al. Elevated levels of interleukin-6 in unstable angina. Circulation 94, 874-877 (1996).
25. Gabriel A, Ahnve S, Wretlind B et al. IL-6 and IL-1 receptor antagonist instable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction. J. Intern. Med. 248, 61-66 (2000).
26. Raymond R, Dehmer G, Theoharides T et al. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am. Heart J. 141, 435-438 (2001).
27. Kanda T, Inoue M, Kotajima N et al. Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction. Cardiology 93, 191-196 (2000).
28. Finkel M, Hoffman R, Shen L et al. Interleukin-6 as a mediator of stunned myocardium. Am. J. Card. 71, 1231-1232 (1993).
29. Jones K, Brull D, Brown L et al. Interleukin-6 and the prognosis of abdominal aortic aneurysms. Circulation 103, 2260-2265 (2001).
30. Nossuli T, Lakshminarayanan V, Baumgarten G et al. A chronic mouse model of myocardial ishemia reperfusion: essential in cytokine studies. Am. J. Physiol. Heart Circ. Physiol. 278, H1049-H1055 (2000).
31. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice. Application to clinical and public health practice: a statement for healthcare professionals from The Centers for Disease Control and Prevention and the American Heart Association. Circulation 107, 499-511 (2003).
32. Missouris LG, Belli AM, MacGregor GA et al. Apparent heart failure: a syndrome caused by renal artery stenoses. Heart 83, 152-155 (2000).
33. Gray B, Olin J, Childs MB et al. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc. Med. 7, 275-279 (2002).
34. Safian RD, Testor SC. Renal-artery stenosis. N. Engl. J. Med. 344(6), 431-442 (2001).
35. Slovut DP, Olin JW et al. Fibromuscular Dysplasia. N. Engl. J. Med. 350(18), 1862-1871 (2004).
36. Caps MT, Ebikili B, Melin JP. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98, 2866-2872 (1998).
37. Wynckel A, Ebikili B, Melin JP et al. Long-term follow-up of acute renal failure casued by angiotensin-converting enzyme inhibitors. Am. J. Hypertens. 11, 1080-1086 (1998).
38. Taylor DC, Kettler MD, Moneta GL et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J. Vasc. Surg. 7, 363-369 (1988).
39. Strandness DE. Duplex imaging for the detection of renal artery stenosis. Am. J. Kid. Dis. 24, 674-678 (1994).
40. Olin JW, Piedmonte MR, Young JR et al. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann. Intern. Med. 122, 833-838 (1995).
41. Cohn EJ, Benjamin ME, Sandager GP et al. Can intrarenal duplex waveform analysis predict successful renal artery revascularization? J. Vasc. Surg. 28, 471-481 (1998).
42. Fleischmann D. Multiple detector row CT angiography of the renal and mesenteric vessels. Eur. J. Radiol. 45(Suppl. 1), S79-S87 (2003).
43. Vasbinder GBC, Nelemans PJ, Kessels AGH et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann. Intern. Med. 141, 674-682 (2004).
44. Eidt JF, Fry RE, Clagett GP et al. Postoperative follow-up of renal artery reconstruction with duplex ultrasound. J. Vasc. Surg. 8, 667-673 (1988).
45. Dorros G, Jaff M, Mathiak L et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 98, 642-647 (1998).
46. Bucek RJ, Puchner S, Reiter M et al. Multidetector CT angiography with perfusion analysis in the surveillance of renal artery stents. J. Endovasc. Ther. 11, 139-143 (2004).
47. Vijayvergiya R, Thingam SK, Hariram V et al. Coronary artery bypass surgery or percutaneous renal revascularization: which one first? J. Endovasc. Ther. 11(3), 351 (2004).
48. Martin-Ucar AE, Patel RL. Preventive stent placement for renal artery stenosis prior to emergent coronary artery bypass grafting. J. Endovasc. Ther. 9, 218-220 (2002).
49. Korsakas S, Mohaupt MG, Dinkel HP et al. Delay of dialysis in end stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Internatl 65, 251-258 (2004).
50. Radermacher J, Charan A, Bleck J et al. Use of doppler ultrasonography to predict the outcome of therapy for renal artery stenosis. N. Engl. J. Med. 344(6), 410-417 (2001).
51. Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter Cardiovasc. Interv. 46, 245-248 (1999).
52. Harb TS, Laird JR, Dieter RS et al. Renal artery stenting using gadolinium based arteriography in patients with baseline renal insufficiency. J. Endovasc. Ther. 11, 553-559 (2004).
53. Henry M, Henry I, Klonaris C et al. Renal angioplasty and stenting under protection: the way for the future? Cathet. Cardiovasc. Interv. 60, 299-312 (2003).
54. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J. Vasc. Surg. 38, 962-968 (2003).
55. Dangas G, Laird JR, Mehran R et al. Intravascular ultrasound-guided renal artery stenting. J. Endovasc. Ther. 8, 238-247 (2001).
56. Munneke GJ, Engelke C, Morgan RA, Belli A-M. Cutting balloon angioplasty for resistant renal artery in-stent restenosis. J. Vasc. Interv. Radiol. 13, 327-331 (2002).
57. Ivanovic V, McKusick MA, Johnson CM III et al. Renal artery stent placement: complications at a single tertiary care center. J. Vasc. Interv. Radiol. 14, 217-225 (2003).
58. White CJ, Ramee SR, Collins TJ et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J. Am. Coll. Cardiol. 30, 1445-1450 (1997).
59. Bakker J, Goffette PP, Henry M et al. The Erasme study: a multicenter study on the safety and technical results of the Palmaz stent used for the treatment of atherosclerotic ostial renal artery stenosis. Cardiovasc. Interv. Radiol. 22, 468-474 (1999).
60. Dieter RS, Laird JR. Overview of restenosis in peripheral arterial interventions. Endovasc. Today 1-3 (2004).
61. Surowiec SM, Sivamurthy N, Rhodes JM et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann. Vasc. Surg. 17, 650-655 (2003).
62. Van Jaarsveld BC, Krijmen P, Pietoman M et al. The effect of ballon angioplasty on hypertension in atherosclerotic renal artery stenosis. N. Engl. J. Med. 342(13), 1007-1014 (2000).
63. Zoltan G et al. Renal artery stenosis: searching for the alogorithms for diagnosis and treatment. J. Am. Coll. Cardiol. 41(8), 1312-1315 (2003).
64. Nordmann A, Woo K, Parkes R et al. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am. J. Med. 114, 44-50 (2003).
65. Harden PN, MacLead MJ, Rodger RS et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 349, 1133-1136 (1997).
66. Watson PS, Hadjipetron P, Cox SV et al. Effect of renal artery stenting on renal function and size in patients with atheroscerotic renovascular disease. Circulation 102, 1671-1677 (2000).